广济药业(000952.SZ)取得甲钴胺片药品注册证书

Core Viewpoint - Guangji Pharmaceutical (000952.SZ) has received the drug registration certificate for Mecobalamin tablets from the National Medical Products Administration, marking a significant advancement in the company's product portfolio for the treatment of peripheral nerve diseases [1] Group 1 - The approval of the Mecobalamin tablet registration certificate signifies important progress in the company's product layout in the field of peripheral nerve disease treatment [1] - This approval provides domestic patients with high-quality domestic drug options [1]